EdgarLookup

ADIAL PHARMACEUTICALS, INC. — 8-K Filings

141 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ADIAL PHARMACEUTICALS, INC. (ADIL), sorted by most recent first. Each row links to the full filing on EdgarLookup. ADIAL PHARMACEUTICALS, INC. has filed 141 8-K documents with the SEC since 2011. To view all SEC filings by ADIAL PHARMACEUTICALS, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 25-NSE 3 4 4/A 424B3 424B4 424B5 8-A12B 8-A12B/A 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT FWP NT 10-Q NT 10-Q/A POS AM PRE 14A PRER14A RW S-1 S-1/A S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-26-024336 Mar 6, 2026
8-K CURRENT REPORT 0001213900-26-022718 Mar 3, 2026 Feb 26, 2026
8-K CURRENT REPORT 0001213900-26-019639 Feb 24, 2026 Feb 23, 2026
8-K CURRENT REPORT 0001213900-26-012274 Feb 4, 2026 Feb 3, 2026
8-K CURRENT REPORT 0001213900-26-001790 Jan 6, 2026 Jan 5, 2026
8-K CURRENT REPORT 0001213900-25-116666 Dec 1, 2025 Nov 25, 2025
8-K CURRENT REPORT 0001213900-25-110385 Nov 14, 2025
8-K CURRENT REPORT 0001213900-25-087925 Sep 16, 2025
8-K CURRENT REPORT 0001213900-25-083719 Sep 3, 2025 Sep 2, 2025
8-K CURRENT REPORT 0001213900-25-076085 Aug 14, 2025
8-K CURRENT REPORT 0001213900-25-070671 Aug 1, 2025 Jul 31, 2025
8-K CURRENT REPORT 0001213900-25-070642 Aug 1, 2025
8-K CURRENT REPORT 0001213900-25-064467 Jul 16, 2025 Jul 14, 2025
8-K CURRENT REPORT 0001213900-25-062800 Jul 10, 2025 Jul 9, 2025
8-K CURRENT REPORT 0001213900-25-055700 Jun 18, 2025 Jun 16, 2025
8-K CURRENT REPORT 0001213900-25-054839 Jun 16, 2025
8-K CURRENT REPORT 0001213900-25-049451 May 30, 2025 May 23, 2025
8-K FORM 8-K 0001213900-25-043733 May 15, 2025 May 14, 2025
8-K CURRENT REPORT 0001213900-25-043730 May 15, 2025
8-K CURRENT REPORT 0001213900-25-040724 May 7, 2025 May 2, 2025
8-K CURRENT REPORT 0001213900-25-038442 May 1, 2025 Apr 28, 2025
8-K CURRENT REPORT 0001013762-25-000999 Mar 21, 2025 Mar 20, 2025
8-K CURRENT REPORT 0001213900-25-021738 Mar 7, 2025 Mar 5, 2025
8-K CURRENT REPORT 0001213900-25-019779 Mar 4, 2025
8-K CURRENT REPORT 0001213900-25-016826 Feb 25, 2025
8-K CURRENT REPORT 0001213900-25-002855 Jan 13, 2025
8-K CURRENT REPORT 0001213900-25-002106 Jan 8, 2025
8-K CURRENT REPORT 0001213900-24-110191 Dec 18, 2024 Dec 13, 2024
8-K CURRENT REPORT 0001213900-24-106554 Dec 6, 2024 Dec 5, 2024
8-K CURRENT REPORT 0001213900-24-099633 Nov 18, 2024 Nov 14, 2024
8-K CURRENT REPORT 0001213900-24-096796 Nov 12, 2024
8-K CURRENT REPORT 0001213900-24-094344 Nov 5, 2024 Nov 1, 2024
8-K CURRENT REPORT 0001213900-24-036613 Apr 26, 2024 Apr 24, 2024
8-K CURRENT REPORT 0001213900-24-034186 Apr 18, 2024
8-K CURRENT REPORT 0001213900-24-033471 Apr 16, 2024 Apr 10, 2024
8-K CURRENT REPORT 0001213900-24-020440 Mar 6, 2024 Mar 1, 2024
8-K CURRENT REPORT 0001213900-24-004505 Jan 18, 2024 Jan 17, 2024
8-K CURRENT REPORT 0001213900-24-003750 Jan 16, 2024 Jan 11, 2024
8-K CURRENT REPORT 0001213900-23-091094 Nov 29, 2023
8-K CURRENT REPORT 0001213900-23-090561 Nov 28, 2023 Nov 21, 2023
8-K CURRENT REPORT 0001213900-23-087129 Nov 14, 2023
8-K CURRENT REPORT 0001213900-23-083634 Nov 6, 2023 Nov 2, 2023
8-K CURRENT REPORT 0001013762-23-006323 Oct 24, 2023 Oct 19, 2023
8-K CURRENT REPORT 0001213900-23-079677 Sep 27, 2023 Sep 26, 2023
8-K CURRENT REPORT 0001213900-23-078339 Sep 21, 2023 Sep 18, 2023
8-K CURRENT REPORT 0001213900-23-075549 Sep 11, 2023
8-K CURRENT REPORT 0001213900-23-070108 Aug 23, 2023 Aug 21, 2023
8-K CURRENT REPORT 0001213900-23-069142 Aug 21, 2023
8-K CURRENT REPORT 0001213900-23-069028 Aug 18, 2023 Jun 30, 2023
8-K CURRENT REPORT 0001213900-23-063213 Aug 4, 2023 Aug 3, 2023